CASE REPORT
Accepted on 29 Sep 2025
Case Report: Fluzoparib Combined Exemestane in gBRCA2-mutated HR+/HER2− Advanced Breast Cancer
doi 10.3389/fphar.2025.1673418
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- New Mechanisms for Anti-Cancer Drugs: Volume II
New Mechanisms for Anti-Cancer Drugs: Volume II
131
Total downloads
1,640
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Drug Discovery
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: